Article
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
World journal of gastroenterology - 14 May 2015
Terrier Benjamin, Lapidus Nathanael, Pol Stanislas, Serfaty Lawrence, Ratziu Vlad, Asselah Tarik, Thibault Vincent, Souberbielle Jean-Claude, Carrat Fabrice, Cacoub Patrice
Abstract excerpt
AIM: To investigate if correction of hypovitaminosis D before initiation of Peg-interferon-alpha/ribavirin (PegIFN/RBV) therapy could improve the efficacy of PegIFN/RBV in previously null-responder patients with chronic genotype 1 or 4 hepatitis C virus (HCV) infection. METHODS: Genotype 1 or 4 HCV-infected patients with null response to previous PegIFN/RBV treatment and with hypovitaminosis D (< 30 ng/mL)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
